Medite Cancer Diagnostics Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.15 |
Market Cap |
$2.67 M |
Shares Outstanding |
86.2 M |
Public Float |
19.53 M |
Address |
4203 SW 34th Street Orlando Florida 32811 United States |
Employees | - |
Website | http://www.medite-group.com |
Updated | 07/08/2019 |
MEDITE Cancer Diagnostics, Inc. is a medical technology company which engages in cancer diagnostics instruments and consumables for histology and cytology laboratories. It specializes in developing, manufacturing, and marketing of molecular biomarkers premium medical devices and consumables for detection, risk assessment and diagnosis of cancer, precancerous conditions, and related diseases. It operates through the following segments: United States, Germany, and Poland. |